Jnba Financial Advisors Gsk PLC Transaction History

Jnba Financial Advisors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$42.05 - $47.77 $2,396 - $2,722	57 Added 4.82%	1,239 $54,000
Q1 2022 Apr 29, 2022	SELL	$40.23 - $47.74 $3,500 - $4,153	-87 Reduced 6.86%	1,182 $52,000
Q4 2021 Feb 03, 2022	BUY	$38.88 - $45.31 $16,835 - $19,619	433 Added 51.79%	1,269 $56,000
Q3 2021 Nov 10, 2021	BUY	$38.79 - $43.16 $16,563 - $18,429	427 Added 104.4%	836 $32,000
Q4 2019 Feb 10, 2020	BUY	$42.0 - $48.25 $12,054 - $13,847	287 Added 235.25%	409 $19,000
Q1 2019 May 01, 2019	SELL	$38.57 - $42.69 $6,672 - $7,385	-173 Reduced 58.64%	122 $5,000
Q4 2018 Feb 07, 2019	BUY	$37.8 - $42.69 $6,425 - $7,257	170 Added 136.0%	295 $11,000
Q3 2018 Nov 01, 2018	SELL	$39.75 - $42.69 $8,029 - $8,623	-202 Reduced 61.77%	125 $5,000
Q2 2018 Jul 17, 2018	BUY	$39.61 - $42.76 $118 - $128	3 Added 0.93%	327 $13,000
Q1 2018 May 07, 2018	BUY	$36.18 - $40.15 $7,308 - $8,110	202 Added 165.57%	324 $324,000
Q2 2017 Aug 14, 2017	BUY	N/A	122	122 $5,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Jnba Financial Advisors with notifications on news.